Real-time enrollment status for this e-cigarette use clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:52 PM UTC
| NCT Number | NCT06372899 |
| Recruiting Status | Recruiting |
| Condition | E-cigarette Use |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | March 12, 2026 (Mar 12, 2026) |
As of July 13, 2026: Clinical trial NCT06372899 is currently recruiting participants. This clinical trial study for e-cigarette use is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06372899 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06372899 was last updated Mar 12, 2026 (March 12, 2026). HelloStudys verifies this status automatically.